Differential expression of host oncogenes in human papillomavirus-associated nasopharyngeal and cervical epithelial cancers

  • 0Department of Biochemistry, Cell & Molecular Biology/West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana.

|

|

Summary

This summary is machine-generated.

This study reveals that AKT mRNA is differentially expressed in cervical and nasopharyngeal cancers, unlike IQGAP1 and MMP16, irrespective of human papillomavirus (HPV) infection status.

Area Of Science

  • Oncology
  • Molecular Biology
  • Virology

Background

  • Human papillomavirus (HPV)-related cervical and nasopharyngeal cancers exhibit distinct molecular oncogenic pathways.
  • Differential expression of oncoproteins is a potential factor contributing to these disparities.

Purpose Of The Study

  • To investigate the expression patterns of host oncogenes (AKT, IQGAP1, MMP16) in HPV-associated cervical and nasopharyngeal cancers.
  • To compare these expression patterns between cancer tissues and non-cancerous tissues.

Main Methods

  • Tissue screening using Hematoxylin and Eosin staining.
  • HPV detection via PCR.
  • Protein expression analysis using immunohistochemistry.
  • mRNA profiling of oncogenes using RT-qPCR.

Main Results

  • AKT and IQGAP1 proteins were significantly upregulated in epithelial cancers compared to non-cancerous tissues.
  • IQGAP1 and MMP16 mRNA levels were higher in cancers, but AKT mRNA levels were not significantly different.
  • AKT mRNA levels were significantly elevated in cervical cancer (CC) compared to nasopharyngeal cancer (NPC).
  • No significant differences in protein levels of AKT, IQGAP1, and MMP16 were observed between CC and NPC.
  • Oncoprotein expression levels did not significantly differ between HPV-positive and HPV-negative cancer biopsies.

Conclusions

  • AKT mRNA exhibits differential expression in cervical and nasopharyngeal cancers, independent of HPV status.
  • IQGAP1 and MMP16 mRNA and protein expression patterns require further investigation in these cancer types.
  • The study highlights distinct molecular profiles that may influence cancer development and progression.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer 01:03

5.0K

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

Mechanisms of Retrovirus-induced Cancers 01:51

5.1K

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...

Cancer-Critical Genes I: Proto-oncogenes 01:33

8.8K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...